405 filings
Page 7 of 21
6-K
6vc0dr91hyjdw7i3c
11 Sep 18
Intellipharmaceutics Closes US$0.5 Million Convertible Debenture Financing
12:00am
424B3
rcagvq3299e3oxqj75q
11 Sep 18
Prospectus supplement
12:00am
424B3
cyyec8s 8l
15 Aug 18
Prospectus supplement
5:17pm
6-K
1w3h8cpj3vbvf
15 Aug 18
Report of Voting Results
5:11pm
424B3
jy3h 1fzeq
9 Aug 18
Prospectus supplement
12:04pm
EFFECT
4ri zy3do
9 Aug 18
Notice of effectiveness
12:15am
CORRESP
ap347 rrq
7 Aug 18
Correspondence with SEC
12:00am
F-1/A
2xt yni51
3 Aug 18
Registration statement (foreign) (amended)
5:26pm
F-1/A
qb1ft 9sq
3 Aug 18
Registration statement (foreign) (amended)
12:00am
6-K/A
nh2x o0u41fizzk
24 Jul 18
Current report (foreign) (amended)
5:22pm
UPLOAD
dv8in w5f3
23 Jul 18
Letter from SEC
12:00am
F-1
rb78c
18 Jul 18
Registration statement (foreign)
9:55pm
6-K
jyht86azljlynrlg
16 Jul 18
Primary Document
5:06pm
6-K
uwp9bfi
13 Jul 18
Special Meeting of Shareholders
5:09pm
SC 13G
mb2gq8kp4lvt
11 Jun 18
Intellipharmaceutics International Inc.
4:43pm
6-K
rhfujp55
8 Jun 18
Intellipharmaceutics Receives Anticipated Additional Staff Determination Letter from Nasdaq
5:26pm
6-K
xefml6 wvc428v6verg
22 May 18
Primary Document
4:08pm
6-K
lw7qesflucm3dw7 f8
16 May 18
Intellipharmaceutics Reports Director Election Results
8:05am
6-K
iyihcx7i0xfll8y
8 May 18
Intellipharmaceutics Announces Start of Intranasal Human Abuse
8:05am
6-K
b8sz9 6wz
27 Apr 18
Primary Document
8:09am